28th July 2023
The findings could help us to distinguish who will benefit from treatment
Read more15th June 2023
The findings could help explain why cancer drugs that target the molecule MET work for some people but not others.
Read more22nd May 2023
Melanoma cells rewire their mitochondria, but reversing this could make tumour cells less invasive.
Read more15th May 2023
The results suggest new strategies to overcome the cancer’s defences and treat patients more effectively
Read more12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more25th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Dr Angus Cameron, have found a way to modulate the invasive behaviour of pancreatic cancer by targeting a non-cancerous cell type found within pancreatic tumours. The findings, published in Cell Reports, provide valuable insights into the biology of pancreatic cancer progression, and could help to drive improvements in cancer treatment.
Read more